|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 822.90 BDT | +4.03% |
|
+7.65% | +16.23% |
| Market Cap | 1.82B 14.72M 12.86M 11.9M 10.92M 20.66M 1.42B 21.02M 142M 55.73M 692M 55.26M 54.05M 2.39B | P/E 2024 |
189x | P/E 2025 | 369x |
|---|---|---|---|---|---|
| Enterprise Value | 2.32B 18.82M 16.45M 15.21M 13.96M 26.42M 1.81B 26.88M 181M 71.27M 886M 70.67M 69.12M 3.06B | EV / Sales 2024 |
10.4x | EV / Sales 2025 | 10.7x |
| Free-Float |
22.75% | Yield 2024 |
0.13% | Yield 2025 | 0.12% |
| 1 day | +4.03% | ||
| 1 week | +7.65% | ||
| Current month | +8.78% | ||
| 1 month | +7.78% | ||
| 3 months | +8.38% | ||
| 6 months | +15.98% | ||
| Current year | +16.23% |
| 1 week | 757 |  | 833 |
| 1 month | 750 | | 833 |
| Current year | 689 | | 833 |
| 1 year | 681 | | 909 |
| 3 years | 511 | | 1,302.3 |
| 5 years | 375.3 | | 1,302.3 |
| 10 years | 294.5 | | 1,302.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | - | - | |
| Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | - | |
| Director/Board Member | - | - | |
Nurjehan Hudda
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.03% | +7.65% | -8.01% | +53.35% | 15.41M | |
| -0.07% | +3.28% | +12.89% | +81.75% | 48.66B | |
| +0.59% | -1.21% | +67.38% | +116.30% | 35.52B | |
| -0.59% | -0.16% | -4.12% | +38.67% | 12.07B | |
| -0.26% | +0.51% | +19.25% | +93.82% | 11.99B | |
| +1.13% | +1.15% | +32.83% | +126.50% | 9.29B | |
| -1.76% | -5.73% | +41.23% | -7.49% | 6.92B | |
| +0.50% | +0.58% | +19.74% | +38.26% | 7B | |
| -0.46% | +2.84% | +2.73% | +225.72% | 6.74B | |
| +7.04% | +14.92% | -10.65% | +29.12% | 6.36B | |
| Average | +0.99% | +2.25% | +17.33% | +79.60% | 14.46B | |
| Weighted average by Cap. | +0.34% | +1.28% | +26.84% | +88.53% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 219M 1.78M 1.55M 1.44M 1.32M 2.5M 171M 2.54M 17.14M 6.73M 83.64M 6.68M 6.53M 289M | 231M 1.87M 1.63M 1.51M 1.39M 2.62M 180M 2.67M 18.01M 7.08M 87.93M 7.02M 6.86M 304M |
| Net income | 9.68M 78.49K 68.6K 63.44K 58.22K 110K 7.56M 112K 757K 297K 3.69M 295K 288K 12.75M | 5.31M 43.03K 37.62K 34.79K 31.92K 60.41K 4.15M 61.46K 415K 163K 2.02M 162K 158K 6.99M |
| Net Debt | 445M 3.6M 3.15M 2.91M 2.67M 5.06M 347M 5.15M 34.74M 13.65M 170M 13.53M 13.24M 585M | 506M 4.1M 3.59M 3.32M 3.04M 5.76M 395M 5.86M 39.56M 15.54M 193M 15.41M 15.07M 667M |
Employees
474
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/07/26 | BDT 822.90 | +4.03% | 12,480 |
| 15/07/26 | BDT 791.00 | +2.51% | 5,963 |
| 14/07/26 | BDT 771.60 | +0.38% | 1,683 |
| 13/07/26 | BDT 768.70 | +1.48% | 1,750 |
| 12/07/26 | BDT 757.50 | -0.42% | 122 |
- Stock Market
- Stocks
- AMBEEPHA Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
